Literature DB >> 1875419

Chronic obstructive pulmonary disease in blacks and whites: pulmonary function norms and risk factors.

R F Gillum1.   

Abstract

Chronic obstructive pulmonary disease (COPD) and asthma are significant causes of illness and death in blacks. Racial differences in normal values of pulmonary function tests must be considered in both patient care and research. Assessment of risk factors is an important part of COPD management and prevention. An extensive review of data from the National Center for Health Statistics and from other population-based studies confirmed lower lung volumes in blacks compared to whites. However, the ratio of forced expiratory volume in 1 second to forced vital capacity was not lower in blacks; racial differences in flow rates were inconsistently reported. Thoracic dimensions were smaller in blacks than in whites in healthy populations. The cause and the physiologic and pathophysiologic significance of these racial differences are unknown. Population-based studies in blacks have firmly established only age and cigarette smoking as risk factors for COPD other than asthma. In 1987, 43% of black men aged 45 and older smoked cigarettes compared to only 30% of white men. Further research is needed on racial differences in pulmonary function and the effects of multiple risk factors to enhance understanding of COPD etiology and prevention. More vigorous smoking prevention and cessation efforts should be targeted for blacks by physicians and public health organizations.

Entities:  

Mesh:

Year:  1991        PMID: 1875419      PMCID: PMC2627087     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  28 in total

1.  Smoking by blacks and whites: socioeconomic and demographic differences.

Authors:  T E Novotny; K E Warner; J S Kendrick; P L Remington
Journal:  Am J Public Health       Date:  1988-09       Impact factor: 9.308

2.  Protease inhibitor profile of black Americans with and without chronic cardiopulmonary disease.

Authors:  R C Young; V E Headings; A L Henderson; S Bose; R L Hackney
Journal:  J Natl Med Assoc       Date:  1978-11       Impact factor: 1.798

3.  Distribution of forced vital capacity and forced expiratory volume in one second in children 6 to 11 years of age.

Authors:  D W Dockery; C S Berkey; J H Ware; F E Speizer; B G Ferris
Journal:  Am Rev Respir Dis       Date:  1983-09

4.  Roentgenographic determination of total lung capacity: normal values from a National Population Survey.

Authors:  R J O'Brien; T A Drizd
Journal:  Am Rev Respir Dis       Date:  1983-11

5.  Ventilatory capacity in Nigerian school children.

Authors:  O Oduwole; W I Aderele; M C Tweedie
Journal:  Ann Trop Paediatr       Date:  1983-09

6.  Coronary heart disease mortality in United States blacks, 1940-1978: trends and unanswered questions.

Authors:  R F Gillum; K C Liu
Journal:  Am Heart J       Date:  1984-09       Impact factor: 4.749

7.  Racially specific reference standards for commonly performed spirometric measurements for black and white children, ages 9-18 years.

Authors:  P B Boggs; A L Stephens; R F Walker; W A Vekovius; G S Acton; R B George
Journal:  Ann Allergy       Date:  1981-10

8.  Ventilatory function in normal Nigerian school children.

Authors:  B O Onadeko; A A Iyun; E O Sofowora; S O Adamu
Journal:  Afr J Med Med Sci       Date:  1979 Mar-Jun

9.  Spirometric standards for healthy black adults.

Authors:  J M Stinson; G L McPherson; K Hicks; V Scott; R Sykes; W Cobbs; G Pierre
Journal:  J Natl Med Assoc       Date:  1981-08       Impact factor: 1.798

10.  The concentration of leukocyte elastase-alpha 1-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects.

Authors:  M Jochum; A Pelletier; C Boudier; G Pauli; J G Bieth
Journal:  Am Rev Respir Dis       Date:  1985-10
View more
  7 in total

1.  Models of care for late-life depression of the medically ill: examples from chronic obstructive pulmonary disease and stroke.

Authors:  Jimmy N Avari; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2014-06-20       Impact factor: 4.105

2.  Racial differences in CT phenotypes in COPD.

Authors:  Nadia N Hansel; George R Washko; Marilyn G Foreman; MeiLan K Han; Eric A Hoffman; Dawn L DeMeo; R Graham Barr; Edwin J R Van Beek; Ella A Kazerooni; Robert A Wise; Robert H Brown; Jennifer Black-Shinn; John E Hokanson; Nicola A Hanania; Barry Make; Edwin K Silverman; James D Crapo; Mark T Dransfield
Journal:  COPD       Date:  2013-02       Impact factor: 2.409

3.  African-American physicians and smoking cessation counseling.

Authors:  B A Berman; A K Yancey; R Bastani; S C Grosser; A Staveren; R A Williams; D Lee
Journal:  J Natl Med Assoc       Date:  1997-08       Impact factor: 1.798

4.  Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults.

Authors:  Jordan Alexander Zach; John D Newell; Joyce Schroeder; James R Murphy; Douglas Curran-Everett; Eric A Hoffman; Philip M Westgate; MeiLan K Han; Edwin K Silverman; James D Crapo; David A Lynch
Journal:  Invest Radiol       Date:  2012-10       Impact factor: 6.016

5.  Development of a modified BODE index as a mortality risk measure among older adults with and without chronic obstructive pulmonary disease.

Authors:  Melissa H Roberts; Douglas W Mapel; Shannon Bruse; Hans Petersen; Toru Nyunoya
Journal:  Am J Epidemiol       Date:  2013-08-08       Impact factor: 4.897

6.  Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.

Authors:  Christina D Williams; Karen M Stechuchak; Leah L Zullig; Dawn Provenzale; Michael J Kelley
Journal:  J Clin Oncol       Date:  2012-12-26       Impact factor: 44.544

7.  Reference values for lung function screening in 10- to 81-year-old, healthy, never-smoking residents of Southeast China.

Authors:  Chunlin Gao; Xiang Zhang; Dan Wang; Zhimin Wang; Jintao Li; Zhongming Li
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.